Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Thomas Schwarz Department of Internal Medicine, Division of Vascular
Medicine, University Hospital "Carl Gustav Carus", D-01307 Dresden,
Germany
Correspondence to: T Schwarz
tho_schwarz@hotmail.com
| The first 150 words of the full text of this article appear below. |
Low molecular weight heparin is safe and effective for the
treatment of deep vein thrombosis.1 We have recently shown
in a randomised study that immobilisation is not
necessary.2 The results challenge the traditional notion
that these patients must be treated in hospital. For selected patients,
outpatient treatment has been shown to be safe and
effective.
3 4
We determined the proportion of patients
who still require admission to hospital and why.
| |
Methods and results |
|---|
Between 1 November 1998 and 15 August 1999 all patients presenting to the vascular diagnostics unit of the University Hospital Dresden, Germany, as outpatients with acute deep vein thrombosis in the leg were prospectively evaluated regarding eligibilty for home treatment. We defined acute deep vein thrombosis as non-compressible deep veins on ultrasonography (UM9 HDI, linear array 4-7 MHz, ATL, Bothell, Washington, DC) and symptoms that had been present for less than two weeks. Written informed consent was obtained from all patients.
On the day of diagnosis
Read all Rapid Responses